What determines continuous performance task performance?

Schizophrenia Bulletin
R J van den BoschM J van Asma

Abstract

The Continuous Performance Task (CPT) is widely used as an indicator of cognitive dysfunction in schizophrenia. It is still unclear, however, exactly what this test measures. We examined the contribution of motor speed, reaction time measures, mental effort, and level of psychopathology to the performance on a double-stimulus CPT. This study included schizophrenia patient groups, depressive patient groups, and patient and normal control groups. Subjects were retested twice: once after 1 week and again at 3 months. In patients with schizophrenia or depression, the sensitivity measure (d') was strongly and consistently associated with motor speed and with the standard deviation of reaction times (response variability) to target stimuli. The association with response variability was also found at followup tests in the control groups. We conclude that in patients with schizophrenia or depression, the sensitivity measure of a double-stimulus CPT is associated with cognitive mechanisms that determine motor proficiency and response variability.

Citations

Oct 24, 2002·Journal of Psychiatric Research·Gerard C KoetsierJan A Bruijn
Sep 11, 2001·Psychiatry Research·A BroerseJ A den Boer
Oct 16, 2002·Psychiatry Research·Esther A E HolthausenRobert J van den Bosch
Nov 5, 2002·Schizophrenia Research·Frank M J WooningsRobert J van den Bosch
Sep 10, 1999·Schizophrenia Research·E A HolthausenR J Van den Bosch
Aug 29, 2003·Journal of Abnormal Psychology·Nikolaos SmyrnisCostas N Stefanis
Nov 6, 2003·Neuropsychology·Esther A E HolthausenRobert J van den Bosch
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·P T MichieA Jablensky
Aug 10, 2006·The Clinical Neuropsychologist·Marije van BeilenAnke Bouma
Aug 7, 2007·The Clinical Neuropsychologist·G H M PijnenborgW H Brouwer
Jul 8, 1998·The Journal of Nervous and Mental Disease·R J van den Bosch, R P Rombouts
Dec 31, 2015·Brain and Cognition·L A JonesP Bright
Jan 30, 2010·Psychiatry Research·Caroline Claudia HiltiKatja Cattapan-Ludewig
Jun 9, 2009·Psychiatry Research·Nikolaos SmyrnisIoannis Evdokimidis
Dec 5, 2006·Psychiatry Research·Esther A E HolthausenRobert J van den Bosch
Jan 24, 2008·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·M AguileraL Fañanás
Jan 9, 2014·Psychophysiology·Christos TheleritisNikolaos Smyrnis
Aug 28, 2004·Comprehensive Psychiatry·Vasilis P BozikasAthanasios Karavatos
Jul 28, 2004·European Psychiatry : the Journal of the Association of European Psychiatrists·Stéphanie Dubal, Roland Jouvent
Dec 24, 1997·Comprehensive Psychiatry·R J van den Bosch, R P Rombouts
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Abigail L Larrison-FaucherAnne B Sereno
Jun 20, 2014·Neuropsychologia·Yunsoo Park, Irwin D Waldman
Jun 1, 2002·Acta Neuropsychiatrica·M van BeilenR van den Bosch
May 2, 2009·Journal of Psychopharmacology·H W ChaseT W Robbins
Jul 11, 2006·Journal of Clinical and Experimental Neuropsychology·H G O M SmidR J van den Bosch
Mar 31, 2018·Computational Psychiatry·Ali YousefiUri T Eden
Dec 29, 2020·Neuroscience and Biobehavioral Reviews·Jutta S MayerChristine M Freitag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.